245070
Tetramethylammonium acetate
≥97%
Synonym(s):
N,N,N-trimethyl-methanaminium acetate
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Linear Formula:
(CH3)4N(OCOCH3)
CAS Number:
Molecular Weight:
133.19
Beilstein:
3571830
EC Number:
MDL number:
UNSPSC Code:
12352116
PubChem Substance ID:
NACRES:
NA.22
Recommended Products
Quality Level
Assay
≥97%
form
solid
mp
184 °C (dec.) (lit.)
SMILES string
CC([O-])=O.C[N+](C)(C)C
InChI
1S/C4H12N.C2H4O2/c1-5(2,3)4;1-2(3)4/h1-4H3;1H3,(H,3,4)/q+1;/p-1
InChI key
MRYQZMHVZZSQRT-UHFFFAOYSA-M
Looking for similar products? Visit Product Comparison Guide
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Daniel L J Thorek et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 25(2), 881-891 (2018-09-27)
The impact of androgen receptor (AR) activity in breast cancer biology is unclear. We characterized and tested a novel therapy to an AR-governed target in breast cancer.Experimental Design: We evaluated the expression of prototypical AR gene products human kallikrein 2
Aleksandra M Urbanska et al.
Cancer biotherapy & radiopharmaceuticals, 35(6), 459-473 (2020-02-06)
An α particle-emitting nanodrug that is a potent and specific antitumor agent and also prompts significant remodeling of local immunity in the tumor microenvironment (TME) has been developed and may impact the treatment of melanoma. Biocompatible ultrasmall fluorescent core-shell silica
Alexey A Nazarov et al.
Dalton transactions (Cambridge, England : 2003), 44(8), 3614-3623 (2014-11-20)
Chemotherapeutics for the treatment of tumorigenic conditions that feature novel modes of action are highly sought after to overcome the limitations of current chemotherapies. Herein, we report the conjugation of the alkylating agent chlorambucil to the RAPTA scaffold, a well-established
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service